BF
BPMC

BOK Financial’s Blueprint Medicines BPMC Stock Holding History

BOK Financial’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8
Closed -$1.02K – 1093
2025
Q2 		$1.02K Hold
8
– – ﹤0.01% 1077
2025
Q1 		$708 Hold
8
– – ﹤0.01% 1200
2024
Q4 		$699 Buy
+8
New +$733 ﹤0.01% 1225

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BOK Financial's BPMC Position: Q3 2025 in Review

BOK Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 8 shares — an estimated $1.02K sold.

BOK Financial first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $1.02K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • BOK Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • BOK Financial sold 8 Blueprint Medicines shares in Q3 2025, an estimated $1.02K.
  • BOK Financial first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
  • BOK Financial's Blueprint Medicines position peaked at $1.02K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on BOK Financial's 13F filing for Q3 2025, filed 13 Nov 2025.